fda semaglutide shortage resolved february 21 2025 Declares of Novo Nordisk's Wegovy, Ozempic Over semaglutide fda shortage As of

The author AK declared that they were an editorial board member of Frontiers, at the time of submission

Our findings suggest that GLP-1RAs may offer benefits beyond their effects on weight and glucose control, particularly for cardiovascular and psychiatric outcomes in people with psoriasis, explained study lead author Professor Ralf Ludwig, dermatologist and professor and director at the Lbeck Institute of Experimental Dermatology, University of Lbeck, Germany

This means insulin release occurs primarily when blood glucose levels are elevated, reducing the risk of hypoglycemia compared to some other diabetes medications

Sato K, Kameda M, Yasuhara T, Agari T, Baba T, Wang F, et al